About Contact Us Careers

Morphine Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 3602
Published Date: Nov 08, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Morphine Landscape

Verve Health Care Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Mayne Pharma Group
Daiichi Sankyo Company Limited
Hikma Pharmaceuticals USA
AbbVie Inc.
Mylan N.V.
Sun Pharmaceutical Industries Ltd.
Alcaliber S.A.
Mallinckrodt Pharmaceuticals
AstraZeneca plc

Browse Key Market Insights with Data Illustration:

Morphine Market Size & Share, Forecast Report 2037

In the News

Pfizer Inc. received U.S. FDA approval for tanezumab, a potential treatment for chronic pain due to moderate to severe osteoarthritis.
Mylan N.V. and Upjohn, a subdivision of Pfizer Inc. collectively established a new pharmaceutical company, Vitaris Inc.

Author Credits: Radhika Pawar

Report ID: 3602
Published Date: Nov 08, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of morphine is assessed at USD 18.2 billion.

The morphine market size was over USD 17.27 billion in 2024 and is projected to reach USD 40.13 billion by 2037, growing at around 6.7% CAGR during the forecast period i.e., between 2025-2037. The growing application of medical morphine as a pain killer is estimated to boost market growth.

North America industry is predicted to dominate majority revenue share of 35% by 2037, due to increasing patient pool of osteoporosis in the region.

The major players in the market include Verve Health Care Ltd., Mayne Pharma Group, Daiichi Sankyo Company Limited, Hikma Pharmaceuticals USA, AbbVie Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Alcaliber S.A., Mallinckrodt Pharmaceuticals, AstraZeneca plc

Inquiry Before Buying Request Free Sample